Blue Crest Capital Management LTD Siga Technologies Inc Transaction History

Blue Crest Capital Management LTD

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$5.22 - $6.1 $60,030 - $70,150	-11,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.66 - $7.89 $65,090 - $90,735	11,500 New	11,500 $69,000

213

35.1M

74.6K

22.8K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.